Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 215 Show results per page	View Search Criteria \| Help With Results


1.		Antithymocyte Globulin and Cyclosporine in Treating Low Risk Patients With Myelodysplastic Syndrome

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Completed				Not specified				Other				SMD/ATG-CSA/2002 NCT00488436

Last Modified: 11/1/1997


2.		Phase II/III Pilot Treatment of Pediatric Non-B, Non-T ALL in First Marrow Relapse (SIMAL #8): Intensive Re-Induction and Reconsolidation Chemotherapy with Subsequent Myeloablative Chemoradiotherapy and Rescue with Either Allogeneic or In Vitro-Purged Autologous Marrow (Summary Last Modified 11/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				under 21 at relapse				NCI				POG-9410 POG-SIMAL-8

Last Modified: 7/11/2007 First Published: 4/1/1998


3.		Phase II/III Randomized Study of Conventional vs T cell Depleted Unrelated Donor Bone Marrow Transplantation for Leukemia, Myelodysplasia, and Lymphoblastic Lymphoma (Summary Last Modified 02/2001)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Closed				55 and under				NCI				MCV-CCHR-9504-2X DUMC-75951, NCI-G98-1388, NCT00003187

Last Modified: 12/6/2007 First Published: 9/24/2003


4.		Phase II/III Randomized Study of Immunotherapy Comprising Cyclosporine, Interferon Gamma, and Interleukin-2 After High-Dose Myeloablative Chemotherapy With Autologous Stem Cell Transplantation in Patients With Refractory or Relapsed Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III, Phase II				Treatment				Completed				Under 30				NCI				COG-AHOD0121 NCT00070187, AHOD0121

Last Modified: 7/11/2007


5.		Phase III Randomized Study of FK506 vs CYSP as GVHD Prophylaxis Following Allogeneic Bone Marrow Transplantation (Summary Last Modified 05/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				12 and over								WSU-Z-1093-93 NCI-V94-0363

Last Modified: 5/24/2006


6.		Phase III Randomized Study of Bone Marrow Transplantation vs Prolonged Intensive Chemotherapy Following Remission Re-Induction after Early First Marrow Relapse in Children with Acute Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				at least 1 + under 20 at diag.				NCI				CCG-1941

Last Modified: 5/16/2008


7.		Phase III Study of Treatment for Childhood Acute Myeloid Leukemia: High vs Standard Dose Cytarabine in the Daunorubicin, Cytarabine, Thioguanine Induction Regimen, Multidrug Resistance (MDR) Modulation with Cyclosporine vs No MDR Modulation During Consolidation, and a Comparison of Allogeneic Bone Marrow Transplant and Consolidative Chemotherapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				under 21				NCI				POG-9421

Last Modified: 7/11/2007


8.		Phase III Randomized Study of FK506 vs CYSP as GVHD Prophylaxis Following Allogeneic Bone Marrow Transplantation (Summary Last Modified 05/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				12 and over				Other				FHCRC-949.00 NCI-V95-0776

Last Modified: 4/8/2005


9.		Phase III Randomized Study of Re-induction with Standard vs Sequential ADE (ARA-C/DNR/VP-16) with and without Cyclosporine in Refractory or Relapsed Acute Myelogenous Leukemia (Summary Last Modified 02/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age								MRC-LEUK-AML-R EU-95037

Last Modified: 1/1/1998


10.		Phase III Randomized, Double-Blind Study of Autologous Bone Marrow Transplantation Alone or with Cyclosporine for Graft-Versus-Tumor Induction in Relapsed, Aggressive non-Hodgkin's Lymphoma (Summary Last Modified 01/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				2 to 65				Other				JHOC-9333 NCI-V96-0897

Select All on One Page


					1 2 3 4 Next >

| | | | | | | |

A Service of the National Cancer Institute